Monthly liver enzyme checks during the first 3 months, then every 3 months ongoing
Some studies report average weight loss of 9.11% after four months with compounded formulations, but these results come from limited datasets without the strict controls that defined the STEP trials

CrossRef Assessing predictive value of contrast-enhanced ultrasound combined with doppler ultrasound for post-transcatheter arterial chemoembolization prognosis in hepatocellular carcinoma Jia-Jiao Qian, Min Xu, Yan-Song Ji World Journal of Gastrointestinal Surgery .2026;[Epub] CrossRef Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial Hyunjae Shin, Youngsu Park, Byeong Geun Song, Won-Mook Choi, Hyung Joon Han, Youngwoo Lee, Tae-Jin Song, Jong-Eun Yeon, Young-Suk Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Joon Hyeok Lee, Jung-Hwan Yoon, Jeong-Hoon Lee Cancer Immunology, Immunotherapy .2026;[Epub] CrossRef First-line systemic therapy for hepatocellular carcinoma: new options Rashida V
The injection form seemed to cause only brief, mild blood pressure increases while retaining efficacy in boosting sexual desire
If you accidentally inject subcutaneously, the compounds will still be absorbed, but peak plasma concentrations will be lower and delayed by 6090 minutes
Our model simulations suggest that chronic usage of APAP at recommended therapeutic levels probably does mild liver damage and may be associated with a reduction in GSH levels that compromise antioxidant defense capacity